JP Morgan Chase
MBOT icon

JP Morgan Chase’s Microbot Medical MBOT Stock Holding History

JP Morgan Chase’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-38
Closed -$43 – 7570
2024
Q4 		$43 Buy
+38
New +$37 ﹤0.01% 7160
2024
Q3 		– Sell
-186
Closed -$190 – 7568
2024
Q2 		$190 Sell
186
-995
-84% -$1.02K ﹤0.01% 6796
2024
Q1 		$1.45K Buy
1,181
+11
+0.9% +$14 ﹤0.01% 6612
2023
Q4 		$1.92K Buy
1,170
+7
+0.6% +$9 ﹤0.01% 6728
2023
Q3 		$1.62K Buy
+1,163
New +$2.52K ﹤0.01% 6577
2021
Q3 		– Sell
-418
Closed -$3K – 6666
2021
Q2 		$3K Buy
+418
New +$3.16K ﹤0.01% 6179
2020
Q4 		– Sell
-4
Closed – – 5810
2020
Q3 		$0 Hold
4
– – ﹤0.01% 5648
2020
Q2 		$0 Buy
+4
New +$27 ﹤0.01% 5569
2019
Q3 		– Sell
-9,068
Closed -$45K – 5863
2019
Q2 		$45K Buy
+9,068
New +$60K ﹤0.01% 5208

Other funds holding MBOT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $28B AUM 26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase's MBOT Position: Q1 2025 in Review

JP Morgan Chase sold out of Microbot Medical (MBOT) in Q1 2025, closing a stake of 38 shares — an estimated $43 sold.

JP Morgan Chase first reported a position in MBOT in Q2 2019 and held it in 9 quarters. The position peaked at $45K in Q2 2019. 43 funds tracked by Wall St. Rank hold MBOT as of Q1 2025.

  • JP Morgan Chase reported no remaining Microbot Medical position as of Q1 2025 after selling out during the quarter.
  • JP Morgan Chase sold 38 Microbot Medical shares in Q1 2025, an estimated $43.
  • JP Morgan Chase first reported a position in Microbot Medical in Q2 2019 and held it in 9 quarters.
  • JP Morgan Chase's Microbot Medical position peaked at $45K in Q2 2019.
  • 43 funds tracked by Wall St. Rank held Microbot Medical as of Q1 2025.

Based on JP Morgan Chase's 13F filing for Q1 2025, filed 12 May 2025.